Preclinical research supports potentially significant anti-tumor effects in model systems through ferroptosis and cell cycle arrest, prominent anti-inflammatory activity via COX-2 inhibition and PPARα/γ activation, broad-spectrum antimicrobial activity with antibiofilm effects and hepatoprotective effects via Nrf2/HO-1. Here, HMOX1 is linked to neoplasm.